Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization. | Immunohematology | 2024 | 38910444 | PubTator, text mining | PubMed |
| Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation. | Contraception | 2024 | 38906503 | PubTator, text mining | PubMed |
| Differences in SARS-CoV-2 antibodies depending on age, blood group, and sex in a Swedish blood donor cohort. | Scand J Clin Lab Invest | 2024 | 38905129 | PubTator, text mining | PubMed |
| 40 years of researching the Del phenotype results in a change of transfusion practice. | Transfusion | 2024 | 38899801 | PubTator, text mining | PubMed |
| Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential. | Air Med J | 2024 | 38897700 | PubTator, text mining | PubMed |
| 'Old is gold' does conventional test tube method still reign supreme? An immuno-haematological survey of anti-D detection and titration in ante-natal cases among major hospitals across India. | Transfus Med | 2024 | 38890119 | PubTator, text mining | PubMed |
| Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti-D prophylaxis in Rh(D)-negative pregnant women? A systematic review and meta-analysis. | Vox Sang | 2024 | 38889996 | PubTator, text mining | PubMed |
| COVID-19-induced immune thrombocytopenia management approach: A case report and literature review. | Clin Case Rep | 2024 | 38883219 | PubTator, text mining | PubMed |
| Depletion of anti-CD47mAb in plasma by genetically modified cells for pre-transfusion testing. | Genes Dis | 2024 | 38882017 | PubTator, text mining | PubMed |
| The Variation of RhD Blood Group in Different Periods in a Patient with Systemic Lupus Erythematosus. | Clin Lab | 2024 | 38868892 | PubTator, text mining | PubMed |
| Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors. | Cureus | 2024 | 38868295 | PubTator, text mining | PubMed |
| The c.254C>A change (p.Ala85Glu) in RHD causing a weak D phenotype. | Transfusion | 2024 | 38856398 | PubTator, text mining | PubMed |
| The prevalence of alloantibodies and ABO RhD blood groups in a cohort of Aboriginal and non-Aboriginal cardiac surgery patients from Australia. | Transfus Apher Sci | 2024 | 38823359 | PubTator, text mining | PubMed |
| Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden. | Blood Transfus | 2024 | 38814881 | PubTator, text mining | PubMed |
| Accuracy of RHC/c genotyping in Chinese Han population. | Transfus Med | 2024 | 38808544 | PubTator, text mining | PubMed |
| Editorial: Structure and function of trans-membrane proteins. | Front Chem | 2024 | 38779308 | PubTator, text mining | PubMed |
| Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort. | Vox Sang | 2024 | 38772910 | PubTator, text mining | PubMed |
| Neonatal screening of ABO/RhD blood group and direct antiglobulin Coombs test. Experience of a single institution. | Bol Med Hosp Infant Mex | 2024 | 38768512 | PubTator, text mining | PubMed |
| Non-RhD alloimmunization in pregnancy: an updated review. | Rev Bras Ginecol Obstet | 2024 | 38765509 | PubTator, text mining | PubMed |
| Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator. | Br J Pharmacol | 2024 | 38757416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=16